Hanna Berak
Warsaw, MZ 01201, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Are Direct-Acting Antivirals Effective and Safe for Hepatitis C Patients with Arterial Hypertension? Evidence from a Large Retrospective Real-World Study.
Journal: Viruses
Published: June 25, 2026
Does rheumatoid arthritis affect the course of chronic hepatitis C and outcomes of antiviral treatment?
Journal: Polish archives of internal medicine
Published: April 14, 2026
Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs.
Journal: World journal of hepatology
Published: February 10, 2025
Plasma levels of soluble PD-1, TIM-3, LAG-3 and galectin-3 and the degree of liver fibrosis in CHC and the impact of successful antiviral treatment on their levels.
Journal: Scientific reports
Published: January 16, 2025
Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes.
Journal: Scientific reports
Published: December 23, 2024
Treatment of Hepatitis C Virus Infections Among Patients of Ukrainian Origin During the Influx of War Refugees to Poland.
Journal: Journal of clinical medicine
Published: October 27, 2024
Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide.
Journal: Clinical and experimental hepatology
Published: May 28, 2024
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients.
Journal: Expert review of anti-infective therapy
Published: May 09, 2024
Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices.
Journal: Pharmacological reports : PR
Published: May 03, 2024
Last Updated: 09/26/2026